Centro para la Salud y la Atención Sanitaria
The Centre for Health and Healthcare identifies and scales up solutions for more resilient, efficient, and equitable healthcare systems..In the next decade, healthcare delivery systems wi...
- Headquarters
- USA
Alnylam Pharmaceuticals
A biopharmaceutical company developing therapeutics based on RNA interference, or RNAi. It is building a broad pipeline of RNAi therapeutics; its most advanced programme is in Phase II human clinical trials for the treatment of respiratory syncytial virus (RSV) infection and is partnered with Cubist and Kyowa Hakko. In addition, the company is developing RNAi therapeutics for the treatment of a wide range of disease areas, including liver cancers, hypercholesterolemia, Huntington's disease, and TTR amyloidosis.
Relacionado Plataformas